A dramatic increase in fat content is causing pains in the dairy industry.

A unique teaching tool at SUNY Cobleskill Ag & Tech also serves as a tribute to a beloved mother. Students spent months ...

Colossal Biosciences aims to freeze millions of animal samples in the hope of saving endangered species, or one day resurrecting them.

A new three-year project will combine gene technology and on-farm trials to bring forward precision-bred oilseed rape resistant to the likes of light leaf spot to farms ...

The vache Canadienne dates back to the beginning of New France, but now it’s on the brink of extinction. A research team at ...

Now that's a cowlick!

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Lexeo Therapeutics is teaming up with Big Pharma Johnson & Johnson's unit Abiomed to tap its Impella heart pump technology in search of a potentially safer and more effective route for cardiac genetic ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of Natera’s expanded 21-gene Fetal Focus single gene ...

Fetal Focus achieved 96% sensitivity and 98% specificity in validation from the prospective blinded EXPAND clinical trial Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision ...

Emily A. Buddle has received funding from the Department of Primary Industries and Regions South Australia, the Australian Research Council and Meat and Livestock Australia. She is currently an ...